Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Trea
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Christian H. Ottensmeier Sanjay Popat Francesco Grossi |
| Publication date | June 20, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |